1088000--3/28/2006--ESSENTIAL_GROUP

related topics

{stock, price, share}

{regulation, government, change}

{product, candidate, development}

{control, financial, internal}

{property, intellectual, protect}

{personnel, key, retain}

{acquisition, growth, future}

{stock, price, operating}

{product, liability, claim}

We have a history of operating losses and expect operating losses and negative operating cash flows for the foreseeable future. We must maintain our clinical research contracts. Our business is dependent on key sponsors and pharmaceutical and biotechnology industries. We depend on key personnel and their ability to manage our growth. We are subject to significant government regulation. We face potential liability associated with clinical research. If we fail to protect our intellectual property rights, or infringe upon the rights of others, our brand and reputation could be impaired. We may require additional funds, which may not be available. A small group of stockholders has substantial control over us. We do not intend to pay dividends on our Class A common stock. There is no public market for our securities and our securities are subject to restrictions on transfer. Our ability to issue preferred stock in the future could adversely affect the rights of holders of Class A common stock.

Full 10-K form ▸

1088000--3/28/2006--ESSENTIAL_GROUP_INC